{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:37:40Z","timestamp":1784551060169,"version":"3.55.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Association Francaise Contre les Myopathies (AFM)","award":["HEALTH-2009-242-31"],"award-info":[{"award-number":["HEALTH-2009-242-31"]}]},{"name":"The Muscular Dystrophy Association of America (MDA)"},{"DOI":"10.13039\/501100000780","name":"The European Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000589","name":"The Chief Scientist Office","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Israel Ministry of Health"},{"name":"The Open University of Israel"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaut.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T23:45:17Z","timestamp":1403567117000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Experimental Autoimmune Myasthenia Gravis (EAMG): From immunochemical characterization to therapeutic approaches"],"prefix":"10.1016","volume":"54","author":[{"given":"Sara","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Aricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debby","family":"Reuveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C.","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.06.003_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0006-3002(60)91377-9","article-title":"A\u00a0specific synthetic polypeptide antigen","volume":"40","author":"Sela","year":"1960","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaut.2014.06.003_bib2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.166.3911.1365","article-title":"Antigenicity: some molecular aspects","volume":"166","author":"Sela","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.06.003_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/bj0850223","article-title":"Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine","volume":"85","author":"Sela","year":"1962","journal-title":"Biochem J"},{"key":"10.1016\/j.jaut.2014.06.003_bib4","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1016\/S0021-9258(19)43428-5","article-title":"The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus","volume":"248","author":"Klett","year":"1973","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.06.003_bib5","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1021\/bi00745a032","article-title":"On immunological cross-reactions between the synthetic ordered polypeptide (L-Pro-Gly-L-Pro)n and several collagens","volume":"12","author":"Maoz","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaut.2014.06.003_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.06.003_bib7","first-page":"1","article-title":"Immunology of the nicotinic acetylcholine receptor","volume":"85","author":"Fuchs","year":"1979","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0019-2791(77)90291-9","article-title":"Immunochemical studies on acetylcholine receptor from torpedo californica","volume":"14","author":"Aharonov","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.jaut.2014.06.003_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.06.003_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1084\/jem.142.3.785","article-title":"Passive transfer of experimental autoimmune myasthenia by lymph node cells in inbred guinea pigs","volume":"142","author":"Tarrab-Hazdi","year":"1975","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.06.003_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/256128a0","article-title":"Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor","volume":"256","author":"Tarrab-Hazdai","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.06.003_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/263329a0","article-title":"Strain differences in the autoimmune response of mice to acetylcholine receptors","volume":"263","author":"Fuchs","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.06.003_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410090609","article-title":"Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects","volume":"9","author":"Burres","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.06.003_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1212\/WNL.36.5.622","article-title":"The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies","volume":"36","author":"Souroujon","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.06.003_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2010.09.007","article-title":"The susceptibility of Aire(-\/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells","volume":"36","author":"Aricha","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1523s95","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2011","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib17","first-page":"11","article-title":"Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis","volume":"19","author":"Abramsky","year":"1975","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(75)92779-8","article-title":"Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis","volume":"2","author":"Aharonov","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.06.003_bib19","first-page":"986","article-title":"Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients","volume":"14","author":"Brenner","year":"1978","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jaut.2014.06.003_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1981.tb33727.x","article-title":"Acetylcholine receptor: molecular dissection and monoclonal antibodies in the study of experimental myasthenia","volume":"377","author":"Fuchs","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.06.003_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-5793(79)80538-4","article-title":"Monoclonal antibodies against defined determinants of acetylcholine receptor","volume":"106","author":"Moshly-Rosen","year":"1979","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2014.06.003_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.06.003_bib23","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1021\/bi00523a041","article-title":"Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site","volume":"20","author":"Mochly-Rosen","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaut.2014.06.003_bib24","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/S0021-9258(18)60652-0","article-title":"Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit","volume":"263","author":"Barkas","year":"1988","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.06.003_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/archneur.1975.00490520054008","article-title":"Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor","volume":"32","author":"Abramsky","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.06.003_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4049\/jimmunol.117.1.225","article-title":"Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine","volume":"117","author":"Abramsky","year":"1976","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib27","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1073\/pnas.75.8.4006","article-title":"Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor","volume":"75","author":"Bartfeld","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.06.003_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/273543a0","article-title":"Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor","volume":"273","author":"Schwartz","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.06.003_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NDT.S8915","article-title":"Current and emerging therapies for the treatment of myasthenia gravis","volume":"7","author":"Mantegazza","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jaut.2014.06.003_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0167-5699(97)01053-0","article-title":"Oral tolerance: immune mechanisms and treatment of autoimmune diseases","volume":"18","author":"Weiner","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaut.2014.06.003_bib31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"Im","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.06.003_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-5728(00)00395-7","article-title":"Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis","volume":"111","author":"Im","year":"2000","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.1996.tb21134.x","article-title":"Oral tolerance in myasthenia gravis","volume":"778","author":"Drachman","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.06.003_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<616::AID-IMMU616>3.0.CO;2-I","article-title":"Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor","volume":"28","author":"Barchan","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib35","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1073\/pnas.96.14.8086","article-title":"Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit","volume":"96","author":"Barchan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.06.003_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.06.003_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-7613(00)80533-6","article-title":"Cytokines induce the development of functionally heterogeneous T helper cell subsets","volume":"8","author":"O'Garra","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.06.003_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2004.04.010","article-title":"Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment","volume":"152","author":"Maiti","year":"2004","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-5728(02)00069-3","article-title":"Protective molecular mimicry in experimental myasthenia gravis","volume":"126","author":"Im","year":"2002","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/08916930903518081","article-title":"Development of novel therapies for MG: studies in animal models","volume":"43","author":"Souroujon","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2014.06.003_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-5728(03)00209-1","article-title":"Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis","volume":"140","author":"Feferman","year":"2003","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0165-2478(85)90058-6","article-title":"Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes","volume":"9","author":"Souroujon","year":"1985","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2014.06.003_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1986.tb20858.x","article-title":"Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis","volume":"475","author":"Souroujon","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.06.003_bib45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1749-6632.1987.tb51336.x","article-title":"Antiidiotypic antibodies in the regulation of experimental autoimmune myasthenia gravis","volume":"505","author":"Souroujon","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.06.003_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2004.04.002","article-title":"The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile","volume":"102","author":"Dalakas","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaut.2014.06.003_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2014.06.003_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.molimm.2004.07.046","article-title":"Therapeutic intravenous immunoglobulins","volume":"42","author":"Lemieux","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1196\/annals.1423.059","article-title":"Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction","volume":"1110","author":"Fuchs","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.06.003_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.04.011","article-title":"Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms","volume":"176","author":"Zhu","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib51","first-page":"58","article-title":"The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model","volume":"10","author":"Fuchs","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaut.2014.06.003_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2007.11.020","article-title":"A\u00a0disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis","volume":"194","author":"Fuchs","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib53","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1096\/fj.01-0072com","article-title":"Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18","volume":"15","author":"Im","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jaut.2014.06.003_bib54","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4","volume":"166","author":"Im","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib55","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Interferon-induced protein 10 (IP-10) and its receptor, CXCR3 are overexpressed in myasthenia gravis: new targets for immunotherapy","volume":"174","author":"Feferman","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib56","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1996.tb00921.x","article-title":"The role of CD40 ligand in costimulation and T-cell activation","volume":"153","author":"Grewal","year":"1996","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2014.06.003_bib58","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y","article-title":"Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis","volume":"28","author":"Shi","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib59","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.165.6.3099","article-title":"IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells","volume":"165","author":"Shi","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib60","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2013chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2014.06.003_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(97)00015-4","article-title":"The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily","volume":"8","author":"Neville","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaut.2014.06.003_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.01.021","article-title":"Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3","volume":"209","author":"Feferman","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.06.003_bib64","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1096\/fj.05-4909fje","article-title":"Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor","volume":"20","author":"Aricha","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jaut.2014.06.003_bib65","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.4049\/jimmunol.159.3.1520","article-title":"Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein","volume":"159","author":"Ekholm","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(99)80068-4","article-title":"Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents","volume":"3","author":"Doherty","year":"1999","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jaut.2014.06.003_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2009.12.012","article-title":"Involvement of phosphodiesterases in autoimmune diseases","volume":"220","author":"Mizrachi","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2008.05.023","article-title":"Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent","volume":"201-202","author":"Menon","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2014.06.003_bib70","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2005.03.011","article-title":"Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma","volume":"164","author":"Luther","year":"2005","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.04.005","article-title":"Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy","volume":"112","author":"Sun","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib72","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.06.003_bib73","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1073\/pnas.0608896103","article-title":"A\u00a050-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses","volume":"103","author":"Ben-David","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.06.003_bib74","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","article-title":"Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia","volume":"175","author":"Liu","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib75","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.177.8.5296","article-title":"Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells","volume":"177","author":"Sheng","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib76","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.4049\/jimmunol.162.10.5757","article-title":"Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells","volume":"162","author":"Shi","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib77","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(00)00411-2","article-title":"Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR","volume":"113","author":"Zhang","year":"2001","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib79","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.06.003_bib80","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex\u00a0vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.06.003_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2012.05.004","article-title":"Pierre Youinou: when intuition and determination meet autoimmunity","volume":"39","author":"Jamin","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.06.003_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.08.006","article-title":"Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ","volume":"46","author":"Invernizzi","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.06.003_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.07.006","article-title":"Abul Abbas: an epitome of scholarship","volume":"45","author":"Gershwin","year":"2013","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:10:01Z","timestamp":1760256601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":83,"alternative-id":["S0896841114001000"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.06.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental Autoimmune Myasthenia Gravis (EAMG): From immunochemical characterization to therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}